EX-FILING FEES 10 d898496dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filling Fee Tables

Schedule TO

(Form Type)

ALX Oncology Holdings Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Transaction Valuation

 

       
     Transaction
Valuation (1)
 

Fee

Rate

  Amount of
Filing Fee (2)
       

Fees to Be Paid

  $2,960,465   0.00015310   $453.25
       

Fees Previously Paid

     
       

Total Transaction Valuation

  $2,960,465    
       

Total Fees Due for Filing

      $453.25
       

Total Fees Previously Paid

     
       

Total Fee Offsets

     
       

Net Fee Due

      $453.25

 

(1)

Estimated solely for purposes of calculating the amount of the filing fee. The calculation of the Transaction Valuation assumes that all stock options to purchase shares of the issuer’s common stock that may be eligible for exchange in the offer will be exchanged pursuant to this offer. This calculation assumes stock options to purchase an aggregate of 3,441,075 shares of the issuer’s common stock, having an aggregate value of $2,960,465 as of November 27, 2024, calculated based on a Black-Scholes option pricing model, will be exchanged or cancelled pursuant to this offer.

(2)

The amount of the filing fee, calculated in accordance with Rule 0-11(b) of the Securities Exchange Act of 1934, as amended, equals $153.10 per $1,000,000 of the aggregate amount of the Transaction Valuation (or 0.01531% of the aggregate Transaction Valuation). The Transaction Valuation set forth above was calculated for the sole purpose of determining the filing fee and should not be used for any other purpose.